Clinical Trials Browser

OTHER × Breast Neoplasms × pegylated granulocyte colony-stimulating factor × Clear all

NCT04009941 2020-10-28

Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer

Phase 4 Completed

Breast Neoplasms, Neutropenia

NCT02761460 2017-06-01

The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia

Phase 3 Unknown

Breast Neoplasms